PATENT GRANTED 1/4/21 U.S. patent number 11,213,666 [Application Number 16/469,799] was granted by the patent office on 2022-01-04 for method for administering a medicament suitable for treating a migraine or cluster headache. This patent grant is currently assigned to Sorrento Therapeutics, Inc.. The grantee listed for this patent is SORRENTO THERAPEUTICS, INC.. Invention is credited to Andrew T. Baker, Luke Hagan, Russell F. Ross.
Abstract
A method for administering a medicament to a patient includes placing a fluid delivery apparatus with the medicament in contact with a portion of the skin of said patient. A flow rate of the medicament from the fluid delivery apparatus is adjusted such that the medicament is delivered to the patient for a predetermined time period. The fluid delivery apparatus includes a controller assembly having a body component defining an axis and a plunger component slidably coupled to the body component. The plunger is positionable between a first position in which the plunger is nearest to the body component and a second position in which the plunger component is furthest from the body component. A bias assembly is positioned between the body component and the plunger component. The bias assembly is configured to apply a two stage force profile to the plunger component.
https://uspto.report/patent/grant/11,213,666
For those of you that don't know what a Medicament means. Please click below
https://www.dictionary.com/browse/medicament
It's a healing substance, medicine, or remedy.
So Sorrento has a Method for administering a medicament suitable for treating a migraine or cluster headache. This patent was granted. This is amazing and I'm guessing this is for Sofusa.
http://www.sofusa.com/development/
Sofusa® DoseDisc™ system with sumatriptan Acute Migraine
Please click and watch the video.
> The trial tracked 775 adults with mild to moderate Covid, who were considered higher risk for severe disease owing to health problems such as obesity, diabetes or heart disease. Half were given a five-day course of the pill, called molnupiravir. In the placebo group, 53 patients (14%) were hospitalised compared with only 28 (7%) of those who received the drug. There were no deaths in the drug group after that time period compared with eight deaths in the placebo group, according to Merck.
Sursa: https://www.theguardian.com/world/2021/oct/01/covid-antiviral-pill-halves-hospitalisations-and-deaths-maker-says
- How changed your ability to study?
- Can you listen to people?
- How changed your work quality
- Can you sleep without headphones with podcast and etc to stop thoughts flow
- What happened with yours time management
- What else changed which I didn't mention.
In a childhood I had diagnosis adhd, but my parents was like: "you just need to control yourself", and me was too thinking that everything was alright, I didn't even know that something was wrong with me. So now I am 19 and in few days I will go to the doctor in a hope to fix my problems. I want to know what expectations will be justified about using medicaments
